NRX Pharma & Neurocare Launch Neuroplastic Therapy for Depression & PTSD | NewsOut

Jan 5, 2026

Healthcare and biotech investors: A new collaborative approach to mental health treatment is launching nationwide.

Reporting from the New York Stock Exchange, Jane King explains that NRX Pharmaceuticals and Neurocare Group AG have announced a joint neuroplastic therapy offering designed to treat depression, PTSD, and other serious mental health conditions.

#NRXPharmaceuticals
#Neurocare
#MentalHealthTreatment
#DepressionTherapy
#PTSDTreatment
#Neuroplasticity
#TMStherapy
#BiotechNews
#HealthcareInnovation
#FirstResponders
#JaneKing
#NewsOut
#NYSE
#Neuroscience
#MentalHealthCare